![](/img/cover-not-exists.png)
Continued Benefit of Tocilizumab Plus Disease-modifying Antirheumatic Drug Therapy in Patients with Rheumatoid Arthritis and Inadequate Clinical Responses by Week 8 of Treatment
Keystone, E. C., Anisfeld, A., Ogale, S., Devenport, J. N., Curtis, J. R.Volume:
41
Language:
english
Journal:
The Journal of Rheumatology
DOI:
10.3899/jrheum.130489
Date:
February, 2014
File:
PDF, 6.17 MB
english, 2014